MDMA Programs CALENDAR
Register here for any of the upcoming MDMA Programs or click on the links below to view full program details including agenda, speakers and location.
|
JULY MEMBERS ONLY WEBINAR What is PR, and is it something that only commercial medtech companies should think about? Through real-world examples, this webinar will bring alive how PR can help facilitate a company’s financing, partnering, clinical-trial recruitment, and commercialization efforts. Early-stage CEOs need to understand that success—a positive story in Forbes or In Vivo, for example, or an invitation to speak at a major investor conference—is the consequence of process . . . and of surefire methods that, when capably applied, produce certain predictable results. |
SEPTEMBER
Medical Technology Executive Forum |
Premarket Approval (PMA) and 510(k) Premarket Notification Seminar |
MDMA Programs - Overview
MDMA Annual Meeting
The MDMA Annual Meeting is a premier industry conference which brings executives from innovative medical technology companies together with healthcares most influential and respected decision makers. The program features speakers from industry, Congress, the Food & Drug Administration, and the Centers for Medicare & Medicaid Services. Attendees include high-level medical technology executives, attorneys, consultants, and others seeking to learn more about trends in the industry.
Coverage, Reimbursement, and Health Policy Conference
MDMA’s Annual Coverage, Reimbursement and Health Policy Conference is a must for medical technology companies seeking to better understand and manage issues related to coverage, coding and payment of medical technologies. Designed for the needs of entrepreneurial device companies, the program covers such topics as, evidence standards for coverage determinations in the US and internationally, payment for new technology, and updates in prospective payment systems. This program helps simplify many of the complex challenges facing device companies and provide the necessary insight from top industry and government officials about the latest trends in coverage, reimbursement and health policy issues.
Premarket Approval (PMA) and 510(k) Premarket Notification Seminar
The Premarket Approval (PMA) and 510(k) Premarket Notification Seminar gives attendees a chance to learn the regulations governing 510(k) and PMA premarket submissions from leading FDA attorneys, industry representatives, and FDA officials. The seminar is designed to help companies understand the technical requirements of submissions, provide practical advice on how to prepare them, help manage and maximize communications with FDA, and avoid fraud and abuse in clinical trials. The program provides valuable insight from a variety of perspectives and gives companies considering submitting a 510(k) or PMA in the future the tools they need to prepare successful submissions.
Medical Technology Executive Forum Providing Entrepreneurs & Innovators Information for Success
This one day interactive workshop provides CEOs and senior medical technology executives with a practical perspective on managing the key issues that directly impact successful product commercialization. Industry experts address attracting and securing funding, recent developments at FDA, navigating reimbursement challenges, protecting and licensing IP and much more. In addition, speakers discuss managing these key elements as a company plans for the successful launch of new products and technologies.
For more information about MDMA programs or membership, please contact Erin Jones at (202) 354-7172.